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Abstract 
 
A genetic contribution to refractive error has been confirmed by the discovery of more 
than 150 associated variants in genome-wide association studies (GWAS). Environmental 
factors such as education and time outdoors also demonstrate strong associations. 
Currently however, the extent of gene-environment or gene-gene interactions in myopia 
is unknown. We tested the hypothesis that refractive error-associated variants exhibit 
effect size heterogeneity, a hallmark feature of genetic interactions. Of 146 variants 
tested, evidence of non-uniform, non-linear effects were observed for 66 (45%) at 
Bonferroni-corrected significance (p<1.1 x 10-4) and 128 (88%) at nominal significance 
(P<0.05). LAMA2 variant rs12193446, for example, had an effect size varying from -0.20 
diopters (95% CI -0.18 to -0.23) to -0.89 diopters (95% CI -0.71 to -1.07) in different 
individuals. SNP effects were strongest at the phenotype extremes and weaker in 
emmetropes. A parsimonious explanation for these findings is that gene-environment or 
gene-gene interactions in myopia are pervasive. 
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Introduction 
The prevalence of refractive error has doubled in several parts of the world in the past 
few decades 1-3. By 2050 it is predicted that 50% of the world population will be myopic 
(near-sighted), with 4.8 billion individuals affected 4. Myopia is associated with axial 
elongation of the eye, which increases the risk of retinal detachment, myopic 
maculopathy, glaucoma, and other pathological complications, making it an increasingly 
common cause of visual impairment and blindness 5-7. Susceptibility to myopia is 
determined both by genetic and environmental factors. Genome-wide association studies 
(GWAS) have identified approximately 150 genetic variants associated with refractive 
error 8-11, including some overlap with monogenic disease gene loci 12. The time children 
spend outdoors, time performing near-viewing tasks, and the number of years in 
education are also strongly associated with myopia development 13-20.  
 
In conventional GWAS analyses of quantitative traits, it is assumed that each copy of a 
genetic variant shifts the phenotype by the same amount in all individuals, i.e. genetic 
effect sizes are assumed to be uniform. This assumption feeds forward into metrics such 
as SNP-heritability, and polygenic risk scores (PRS) used for genetic prediction. However, 
loci with gene-gene (GxG) or gene-environment (GxE) interactions will violate this 
assumption: For these loci the (marginal) effect size of a variant varies from person to 
person, depending on their genotype at other loci or their environmental exposure profile 
(for variants involved in GxG and GxE interactions, respectively). Accordingly, a number 
of elegant studies have used evidence of a non-uniform effect size across individuals as a 
‘signature’ to identify GxG or GxE interaction loci 21-24. A major advantage of this approach 
is that it does not require the identity of the environmental risk factor underlying a GxE 
effect to be pre-specified or measured, nor the identity of the second genetic variant to be 
known when detecting GxG interactions. Instead, the presence of GxG or GxE interaction 
can be inferred using only genotype information for a genetic marker and phenotype 
information for the trait of interest.  
 
Since GxE effects are implicated in myopia susceptibility 25-28, and yet currently very few 
such interacting variants have been discovered, we aimed to comprehensively assess the 
known genetic variants associated with refractive error for involvement in interactions 
by testing for this ‘signature’ of non-uniform genetic effect sizes across individuals. We 
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compared our results for refractive error with those for height, a highly polygenic trait 
with little or no evidence of gene-environment or gene-gene interactions. 
 
Results 
In the sample of 72,985 unrelated, European-ancestry participants whose genotype data 
passed quality control and had phenotype information available, the mean ± SD 
refractive error was -0.25 ± 2.67 diopters (D) and the average age was 57.8 ± 7.8 years.  
 
We assessed 146 genetic variants that showed genome-wide significant association (p < 
5 x 10-8) with refractive error in a recent meta-analysis carried out by the CREAM 
Consortium and 23andMe and that showed evidence of independent replication in the UK 
Biobank sample 11. We coded the risk allele as the allele associated with a more negative 
refractive error.  
 
Conventional ordinary least squares (OLS) analysis    
A standard, ordinary least squares (OLS) linear regression analysis of SNP effects under 
the assumption of constant effect size across all individuals produced very similar results 
to those reported previously in UK Biobank participants11 (Supplementary Table 1). Of 
the 146 variants tested, the strongest effect was for rs12193446 near LAMA2, which was 
associated with a -0.43 D more negative refractive error (95% CI -0.39 to -0.48, p = 1.1 x 
10-77). 
 
Conditional quantile regression and meta-regression (CQR-MR) 
Figure 1 illustrates the CQR-MR analysis process, and contrasts it with OLS regression. 
Whereas an OLS model seeks to minimize the sum of squared residuals between data 
points and the mean effect for each genotype class (AA, AB and BB), a quantile regression 
model seeks to minimize the absolute residuals at a specific quantile of trait distribution 
for each genotype class. Crucially, unlike OLS regression, CQR allows a variant’s genetic 
effect size to vary between individuals, depending on their position in the trait distribution 
(Figure 1).  
 
The type I error rate and statistical power of CQR-MR were investigated (see Methods) and 
full results are presented in the Supplementary Notes 1 and 2. The main finding was a 
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systematic inflation of the type I error rate of CQR-MR that was independent of MAF 
(Supplementary Figure 1), but that this could be readily corrected using a ‘genomic control’ 
approach. This correction was applied in all of the results presented below. The statistical 
power of CQR-MR varied depending on the number of different quantiles included in the 
meta-regression. The use of 9 quantiles spaced equally at 0.1 intervals was found to 
perform well (Supplementary Figure 1) and hence was applied in all of the present 
analyses. 
 
Widespread evidence of non-uniform effects sizes 
CQR-MR was used to determine if effect sizes for the 146 refractive error-associated 
variants differed across individuals depending on their position (i.e. their quantile) in the 
refractive error distribution. Nearly all variants exhibited an inverse-U shaped effect size 
profile, with the strongest effect size in individuals at the extremes of the refractive error 
distribution and a minimum effect size in emmetropic participants near the center of the 
distribution. Representative results are presented in Figure 2 (results for all variants are 
shown in Supplementary Figure 2). For instance, for rs12193446 (LAMA2), which had the 
strongest effect in the conventional OLS analysis, the effect size varied from -0.20 D (95% 
CI -0.18 to -0.23) for individuals near the centre of the trait distribution to -0.89 D (95% CI 
-0.71 to -1.07) for the most highly myopic individuals (Figure 1). Exceptions to the inverse-
U shaped effect size pattern were observed for variants such as rs1649068 (BICC1) and 
rs9388766 (L3MBTL3), which displayed non-constant, yet nearly linear changes in effect 
size across quantiles of the refractive error distribution, along with SNPs such as 
rs9680365 (GRIK1) and rs7449443 (FLJ16171-DRD1), which had essentially flat effect 
size profiles similar to those obtained under the OLS assumption of a constant effect size 
in all individuals. 
 
Quantitative analysis of non-uniform effects 
We used a 3 parameter model to quantify the non-uniformity of effect sizes (see 
Methods). After correcting for multiple-testing by applying a Bonferroni adjusted p-value 
threshold of 0.05/(3 x 146) = 1.1 x 10-4, a total of 66 (45%) of the variants showed 
significant non-uniform effects, i.e. p < 1.1 x 10-4 for the 1 (linear) or 2 (quadratic) 
model coefficients (Table 1 and Supplementary Table 2). Thus, 45% of the genetic 
variants showed statistically significant evidence of differing effect sizes depending 
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where in the refractive error distribution an individual lay, suggestive of the variant’s 
involvement in either a gene-gene or gene-environment interaction. For the rs12193446 
(LAMA2) variant, p = 2.12 x 10-36 for the 1 component, and p = 1.19 x 10-30 for the 2 
component. Notably, only 18 (12%) of the variants failed to show at least nominal 
evidence of an interaction effect (i.e. 1 component and 2 component, p > 0.05).  
 
For comparison, an analogous set of analyses to those performed above were carried out 
for genome-wide significant variants associated with height. For height, only 6% of 
variants (9 out of 148) displayed at least nominal evidence of a non-uniform effect size 
(Supplementary Note 3, Supplementary Tables 3 & 4, and Supplementary Figure 2).  
 
Polygenic risk score interaction with educational attainment 
We used the 146 refractive error-associated variants to create a polygenic risk score 
(PRS) and examined whether this too exhibited a non-uniform effect size in different 
individuals. As shown in Figure 3, the PRS effect size displayed the inverted-U pattern 
across quantiles of the trait distribution as was observed for the majority of individual 
SNPs. In addition, the PRS effect size differed across educational attainment strata. For 
participants from the myopic tail of the refractive error distribution, more time spent in 
education was associated with a larger PRS effect size. For example for those in refractive 
error quantile 0.1, a 1 SD increase in PRS was associated with a -0.82 D (95% CI -0.73 
to -0.90) more negative refractive error in the lowest educational stratum, yet a -1.11 D 
(95% CI -1.02 to -1.18) more negative refractive error for those in the highest education 
stratum (p = 8.9 x 10-83 and p = 1.17 x 10-155, respectively). The largest change in PRS 
effect size due to such an interaction with education was 0.57 D (at quantile 0.2). The PRS 
effect size difference associated with educational attainment was smallest in 
emmetropes. For example, the PRS effect size was within a narrow range of -0.25 to -0.37 
D for participants in quantile 0.6, irrespective of their level of education. For participants 
in the hyperopic tail of the refractive error distribution (quantiles >0.8), the PRS effect 
size was smaller in those with greater educational attainment, opposite to the 
relationship seen in the myopic tail. Thus, for example, for hyperopic participants in 
quantile 0.9, a 1 SD reduction in PRS was associated with a +0.62 D (95% CI +0.55 to 
+0.69) effect on refractive error in those in the lowest education stratum, yet only a 
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+0.41 D (95% CI +0.38 to +0.44) effect in those from the highest education stratum (p = 
6.55 x 10-68 and p = 9.53 x 10-193, respectively).  
 
Discussion 
Evidence of effect size heterogeneity – a signature of involvement in GxG or GxE 
interactions – was found for 88% of the refractive error-associated variants tested. 
Furthermore, the impact of this phenomenon was dramatic: Genetic effect sizes were as 
much as 4-fold higher in certain individuals compared to others. Previous studies of 
refractive error genetics have always assumed that genetic effect sizes are the same in 
every person in the sample, and thus this important source of inter-individual variation 
has remained hidden. 
 
Refractive error-associated variants typically had inverse-U shaped effect size profiles, 
with the strongest effects observed at the phenotype extremes, and effects closer to zero 
in emmetropes. Very few SNPs had constant effects across all quantiles of the sample 
distribution that matched those assumed in conventional analyses. One potential 
explanation for these findings is the process of ‘emmetropization’, in which the rate of 
axial eye elongation during infancy is fine-tuned by a visual feedback loop in order to 
maintain a sharp retinal image 29. We speculate that emmetropization may act as a buffer 
against the myopia- or hyperopia-predisposing effects of genetic risk variants. Thus, 
suppose that, during childhood, a myopia-predisposing risk allele led to a small increase 
in axial eye length. This might subsequently be countered by a slowing of the rate of axial 
elongation via visually-mediated feedback. Furthermore, suppose there exists a limit to 
the amount of axial elongation that the emmetropization system can compensate for (as 
has been proposed for the axial elongation-countering effects of crystalline lens 
thinning30) then in those individuals whose emmetropization limit is surpassed, genetic 
variants would have free reign to attain much higher effects than in those individuals 
whose emmetropization limit is not exceeded. Finding evidence to support a direct role 
for emmetropization in causing the observed genetic effect size heterogeneity of 
refractive error associated variants would likely require studies in animal models; the 
recent discovery of a genetic locus for susceptibility to visually-induced myopia is a first 
step in this direction31.  
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Prior to this work, only a handful of specific GxE interactions, and no GxG interactions had 
been reported for refractive error 25-28. The current work suggests that such interaction 
effects are likely to be widespread. Applying our same analysis methods to a different 
trait, height, yielded far fewer variants with signatures of a GxG or GxE interaction (6% 
for height vs. 88% for refractive error). Given that height and axial eye length share 
genetic determinants in common (genetic correlation 0.1-0.2)32,33, it would be interesting 
to examine genetic effect sizes across quantiles of the axial length distribution, for 
example in samples of emmetropes and myopes.  
 
The PRS findings confirmed the dramatic difference in phenotypic effect exerted by 
refractive error-associated genetic variants in different individuals, which contrasts 
starkly with the simple deterministic effects expected of high risk genotypes. Individuals 
who reached adulthood as emmetropes appeared to have been ‘buffered’ against their 
genetic risk burden, and thus genetic effect sizes in these individuals were 
correspondingly small. By contrast, genetic effect sizes were often several-fold larger in 
individuals who became highly myopic or highly hyperopic by the time they reached 
adulthood. Time spent in education appeared to further modify the phenotypic effects of 
risk SNPs. 
 
Our strategy for detecting inter-individual differences in genetic effect sizes was based on 
a statistical test for variance heterogeneity across genotypes. While variance 
heterogeneity is a signature of GxG and GxE interactions21,34-36, it is not the only cause. 
Parent-of-origin effects will give rise to increased variance heterogeneity in heterozygous 
individuals at loci in which the effect size varies dependent on which parent transmitted 
the risk allele34. Similarly, ‘genetic nurture’, whereby untransmitted alleles in parents (as 
well as transmitted alleles) influence the phenotype37 may also lead to variance 
heterogeneity. For example, if the environment of the child is partly determined by the 
parents’ genotype, then risk alleles inherited by the child will potentially show 
interactions with untransmitted parental alleles, i.e. an inter-generational GxG interaction 
mediated via a GxE interaction for the child. Allelic heterogeneity, whereby multiple 
genotypes in linkage disequilibrium influence the same phenotype, can also give rise to 
variance heterogenity38-40. Finally, examples of genetic variants with striking inter-
individual genetic effect heterogeneity exist for which mechanistic explanations are 
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currently lacking or incomplete. For instance, rs3825942 in LOXL1 is associated with an 
increased risk of exfoliation syndrome in certain populations, but a reduced risk in 
others41 (so called risk allele ‘flipping’), and rs6817105 near PITX2 is associated with an 
approximately 1.6-fold increased risk of atrial fibrillation overall, however the level of 
risk varies widely across populations42. Explanations based on simple GxG or GxE 
interactions have not been able to account for the observed effect size heterogeneity at 
these loci41,42. 
 
To conclude, our study provides evidence that most of the currently-known refractive 
error-associated variants have different effect sizes in different individuals. A 
parsimonious explanation is that the variants are involved in GxG or GxE interactions. The 
phenotypic effect imparted by risk alleles was found to vary as much as 4-fold, with 
greater effects observed for individuals in the phenotype extremes compared to those in 
the center. This variation in inter-individual effects remains hidden when conventional 
analysis methods are used to detect genetic effects. Widespread GxG or GxE interactions 
will contribute to the ‘missing heritability’ for refractive error, and adversely impact the 
accuracy of genetic prediction of children at-risk of developing myopia. 
 
Methods 
Study participants and quality control 
The UK Biobank project is an ongoing cohort study of approximately 500,000 UK adults 
aged 40 to 70 years-old when recruited (2006-2010) 43. Ethical approval for the study 
was obtained from the National Health Service National Research Ethics Service (Ref 
11/NW/0382) and all participants provided written informed consent. Participants 
provided a blood sample, from which DNA was extracted and genotyped using either the 
UK BiLEVE Axiom array or the UK Biobank Axiom Array 44. We analysed data from the 
July 2016 data release for genetic variants in 488,377 individuals imputed to the HRC 45 
reference panel.  
 
Participants self-reported whether they had a university or college degree. An ophthalmic 
assessment was introduced towards the latter stages of UK Biobank recruitment, hence 
only about 25% of participants were examined. Refractive error was measured using 
non-cycloplegic autorefraction (Tomey RC5000; Tomey GmbH Europe, Erlangen-
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Tennenlohe, Germany). The mean spherical equivalent (MSE) refractive error was 
calculated as the sphere power plus half the cylinder power, and averaged between the 
two eyes (avMSE). Individuals who self-reported any of the following eye disorders were 
excluded from the analyses: cataracts, “serious eye problems”, “eye trauma”, a history of 
cataract surgery, corneal graft surgery, laser eye surgery, or other eye surgery in the past 
4 weeks. Individuals whose hospital records (ICD10 codes) indicated a history of the 
following were also excluded: cataract surgery, eye surgery, retinal surgery, or retinal 
detachment surgery. Of 488,377 individuals with genetic information, samples were 
excluded due to: Ocular history (n=48,145, see above), withdrawal of consent (n=8), 
self-report of non white-British ethnicity or genetic principal components indicative of 
non-European ancestry (n=69,938), outlying level of genetic heterozygosity (n=648), or 
refractive error not measured (n=283,352). The remaining 86,286 individuals were 
tested for relatedness using the --rel-cutoff command in PLINK v1.9 46. A genetic 
relationship matrix was created using a linkage disequilibrium (LD)-pruned set of well-
imputed variants (with IMPUTE2 r2 > 0.9, minor allele frequency (MAF) > 0.005, missing 
rate ≤ 0.01, and ‘rs’ variant ID prefix). LD-pruning was accomplished by using the --
indep-pairwise 50 5 0.1 command in PLINK v2 46. One member of each pair with genomic 
relatedness greater than 0.025 was excluded. This resulted in a final sample size of 
72,985 unrelated individuals of European ancestry. 
 
Selection of genetic variants 
Variants associated with refractive error. We originally assessed 149 genetic variants that 
showed genome-wide significant association (p < 5 x 10-8) with refractive error in the 
CREAM Consortium and 23andMe meta-analysis and that replicated in a UK Biobank 
sample 11. The risk allele was coded as the allele associated with a more negative 
refractive error. Of the 149 genetic variants tested, reliable results could be obtained for 
146 (for rs74764079, rs73730144 and rs17837871, with MAFs of 3%, 1% and 1%, 
respectively, there were fewer than 50 participants homozygous for the minor allele; 
hence these variants were excluded).   
 
Variants associated with height. For comparison, we also examined genetic variants 
associated with height. GWAS summary statistics were obtained from Wood et al. 38. We 
restricted our analyses to the 149 genetic variants with the strongest association (i.e. 
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those with the lowest p-values). Reliable results could be obtained for 148 height SNPs 
(Supplementary Information). 
 
Statistical analysis 
A ‘conventional’ OLS regression analysis was carried out to quantify the effect size of each 
of the 146 variants under the assumption of a constant effect size across the full sample. 
Refractive error averaged between the 2 eyes (avMSE) was the dependent variable and 
genotype, age, age-squared, sex and a binary variable indicating genotyping array were 
fitted as covariates. Conditional quantile regression (CQR) 47 was carried out using the 
quantreg package v5.36 in R version 3.5.1, using the same set of covariates as above. We 
used 10,000 Markov-chain-marginal-bootstrap replicates to calculate standard errors. As 
a sensitivity analysis, we also tested linear regression and quantile regression models 
with the first 10 principal components included as covariates. However, including 
principal components in the models did not change parameter estimates substantially, 
hence only the results of the original analyses are reported. 
 
SNP effect estimates and their standard errors from quantile regression at 9 different 
quantiles (0.1, 0.2, 0.3, …, 0.9) were meta-regressed using a mixed-effects model (metafor 
package v2.0.0 in R 48) with the estimated SNP effect at each quantile modelled as the 
dependent variable and the quantile at which these estimates were obtained as the 
independent variable. A term for quantile-squared was also included in the meta-
regression model to test for non-linear genetic effects across quantiles, resulting in the 
model: y = 0 + 1q + 2q2 + e (where, 0 is an intercept term, 1 and 2 are coefficients 
describing the linear and quadratic change in SNP effect across quantiles of the trait 
distribution, respectively, q are the quantiles, and e is the error term). Figure 1 illustrates 
the conditional quantile regression and meta-regression model fitting strategy. 
 
Permutation-based assessment of type I error rate and power 
To assess the type I error and power of the CQR-MR model we used the gold-standard 
method of permutation. The type 1 error rate was assessed in two ways. Firstly, we 
simulated genotypes for ‘null’ SNPs and tested for an association between the true 
phenotype and the null SNP genotype. Secondly, we permuted phenotype values amongst 
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individuals in the sample, and tested for an association between the null phenotype and 
the observed (true) SNP genotypes.  
 
Null phenotype. The avMSE phenotype of the 72,985 individuals in the analysis sample 
was permuted 100 times. For each permutation, the association between the null 
phenotype and the genotype of each of the 149 variants was assessed using CQR-MR. The 
type 1 error rate was calculated as the proportion of SNPs with P<0.05 for each of the 
three meta-regression coefficients (0, 1 and 2) from the total of (100 x 149) = 14,900 
permutations. Null SNPs. The 72,985 individuals in our analysis sample were 
independently assigned genotypes for a biallelic SNP with MAF ranging from 0.05 to 0.45, 
simulated from a binomial distribution. Association between avMSE and the genotype of 
the null SNP was assessed using CQR-MR. The type 1 error rate was calculated as the 
proportion of SNPs with P<0.05 for each of the three meta-regression coefficients (0, 1 
and 2) after simulating 10,000 null SNPs. 
 
To obtain a relative indication of statistical power, the 149 refractive error-associated 
variants were tested for association with the observed avMSE phenotype in samples of 
varying size. Specifically, from the full sample of 72,985 individuals, we selected a random 
sample of 10,000 to 70,000 individuals, in steps of 10,000, and tested each of the 149 
variants for association. This procedure was repeated 20 times. Power was computed as 
the proportion of replicates in which the null hypothesis was rejected at a nominal 
significance level of α = 0.05 (i.e. under the assumption that all 149 variants truly had 
non-linear effect sizes across quantiles). The total number of tests used for these power 
evaluations was 149 x 7 x 20 = 20,860. The same set of covariates as in original analysis 
was included in the CQR step when assessing power and type 1 error. 
 
In the analyses described above, CQR-MR was performed by carrying out quantile 
regression at 9 different quantiles (q = 0.1 to 0.9 in steps of 0.1) followed by meta-
regression of the resulting genetic effect size estimates. In preliminary work, we explored 
the effect on type 1 error rate and power of selecting more or fewer than 9 quantiles, by 
testing: a) 19 quantiles, q = 0.05 to 0.95 in steps of 0.05; b) 10 quantiles, q = 0.05 to 0.95 
in steps of 0.1; c) 5 quantiles, q = 0.1 to 0.9 in steps of 0.2. For simplicity, we refer to 
these CQR-MR models by the number of quantiles included in the meta-regression, i.e. 5, 
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9, 10 or 19. CQR-MR analysis with 9 quantiles performed optimally (Supplementary 
Information and Supplementary Figure 3). 
 
Gene-environment interaction with education 
To test for the presence of gene-environment interaction, we constructed a polygenic risk 
score (PRS) by counting the number of risk alleles (0, 1 or 2) carried by each individual. 
We did not weight these by SNP effect sizes in order to avoid introducing bias by using 
weights obtained from, and applied in, the same sample (UK Biobank). ‘Age completed 
full-time education’ (EduYears) was selected as an exemplar environmental variable. UK 
Biobank participants with a university degree were not asked the age they completed 
full-time education, hence these individuals were assumed to have completed their 
education at the age of 21 years. Age completed education categories with low counts 
were merged with adjacent categories, resulting in 4 final EduYears categories: 13-15, 16, 
17-20 and 21-26 years. We carried out a CQR-MR analysis stratified by EduYears 
category.  
 
Supplementary Information 
Supplementary information include additional text, 3 figures and 4 tables. 
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Figure legends 
 
Figure 1. Conditional quantile regression (CQR) and meta-regression (MR) can identify if genetic 
effect size varies in individuals depending on their position in the trait distribution. In conventional 
ordinary least-squares (OLS) linear regression, SNP effect size is estimated under the assumption 
that it is the same for every person in the sample. Thus, the effect size is calculated as the slope of 
the regression line (dashed blue line in top-left graph) obtained by minimizing the sum of 
squared residuals between data points and the mean, for each genotype class (0, 1 or 2 copies of 
the minor allele). Alternatively, in CQR, the SNP effect size is estimated at a specific quantile of the 
outcome distribution. Analogous to OLS, the effect size is calculated as the slope of the quantile 
regression line (in the top-left graph, the 9 red lines correspond to quantile regression fits for 
quantiles 0.1, 0.2, 0.3, …, 0.9 of the trait distribution). For the variant shown, rs12193446, the 
effect size (slope) differs for individuals in different quantiles of the trait distribution; this can be 
visualized more readily by plotting the effect size at each quantile (black circles with error bars in 
middle-right graph). OLS analysis assumes the effect size is constant across quantiles of the trait 
distribution (horizontal red line in middle-right graph, with dotted red lines indicating 95% CI). 
After using CQR to estimate the SNP effect size at a range of quantiles, the uniformity of the SNP 
effect sizes can be quantitatively assessed using MR (solid blue line in bottom-left graph, with 
dashed blue lines showing 95% CI). 
 
Figure 2. Changes in genetic effect size across the refractive error distribution for a representative 
subset of genetic variants associated with refractive error. Genetic effect size estimates from 
conditional quantile regression (CQR) are represented by the solid black line and their 95% 
confidence intervals are shown by the shaded grey region. The solid red line is the effect size 
estimate from conventional linear regression analysis with its 95% confidence intervals shown by 
the red dashed lines. Effect size estimates from meta-regression are shown with the solid blue 
line with corresponding 95% confidence intervals given by the dashed blue lines. 
 
Figure 3. The effect of educational attainment on refractive error varies across quantiles of the 
refractive error distribution. Each line represents the polygenic risk score (PRS) effect size across 
quantiles for individuals with different times spent in education. Error bars show 95% confidence 
intervals.  
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Table 1. Summary statistics for the 10 strongest associations with refractive error based on conditional quantile regression – meta-regression (CQR-
MR). Confidence intervals and p-values have been corrected for the inflated type I error rate of CQR-MR.  
 
Abbreviations: SNP: single nucleotide polymorphism, CHR: chromosome, BP: base pair, EA: effect allele, 0: meta-regression intercept effect size in dioptres  
per copy of the risk allele, 1 and 2: meta-regression coefficients for the linear and quadratic terms, respectively, CI: confidence interval. 
 
 
SNP Gene(s) 
0 1 2 
Beta [95% CI] P Beta [95% CI] P Beta [95% CI] P 
rs12193446 BC035400_LAMA2 -1.130 [-1.272; -0.988] 8.07 x 10-55 2.995 [2.529; 3.461] 2.12 x 10-36 -2.363 [-2.765; -1.961] 1.19 x 10-30 
rs524952 GOLGA8B_GJD2 -0.673 [-0.758; -0.588] 4.83 x 10-54 1.797 [1.534; 2.06] 7.47 x 10-41 -1.417 [-1.634; -1.200] 1.68 x 10-37 
rs7744813 KCNQ5 -0.543 [-0.631; -0.455] 7.24 x 10-34 1.402 [1.132; 1.672] 2.15 x 10-24 -1.092 [-1.314; -0.870] 5.75 x 10-22 
rs11602008 LRRC4C -0.669 [-0.79; -0.548] 2.60 x 10-27 1.612 [1.250; 1.974] 2.71 x 10-18 -1.131 [-1.421; -0.841] 2.25 x 10-14 
rs1550094 PRSS56 -0.521 [-0.624; -0.418] 4.77 x 10-23 1.441 [1.118; 1.764] 2.08 x 10-18 -1.142 [-1.409; -0.875] 4.90 x 10-17 
rs72621438 SNORA51_CA8 -0.441 [-0.530; -0.352] 2.06 x 10-22 1.089 [0.817; 1.361] 4.46 x 10-15 -0.821 [-1.044; -0.598] 5.85 x 10-13 
rs2326823 BC035400 -0.680 [-0.830; -0.530] 6.17 x 10-19 1.815 [1.341; 2.289] 6.45 x 10-14 -1.429 [-1.831; -1.027] 3.09 x 10-12 
rs10500355 RBFOX1 -0.400 [-0.490; -0.310] 3.63 x 10-18 1.011 [0.734; 1.288] 8.39 x 10-13 -0.775 [-1.003; -0.547] 2.76 x 10-11 
rs6495367 RASGRF1 -0.374 [-0.459; -0.289] 7.17 x 10-18 1.009 [0.747; 1.271] 4.38 x 10-14 -0.833 [-1.049; -0.617] 3.89 x 10-14 
rs2573210 PRSS56 -0.501 [-0.621; -0.381] 2.91 x 10-16 1.414 [1.037; 1.791] 1.94 x 10-13 -1.121 [-1.434; -0.808] 2.26 x 10-12 
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